Why patients have to pay so much for eltrombopag/eltrombopag ethanolamine tablets
Eltrombopag/Eltrombopag ethanolamine tablets (Eltrombopag) has occupied a place in the medical community with its unique efficacy in the treatment of thrombocytopenia. However, many patients are confused by its high price. So, what exactly makes eltrombopag so expensive?
The high cost of new drug research and development is one of the main reasons for the high price of eltrombopag. The research and development process of new drugs is long and full of challenges. From drug design, animal experiments to clinical trials, each link requires a large investment of capital, technology and human resources. As an innovative drug, the research and development cost of eltrombopag is also high, which is also an important reason for its high price.
The special efficacy of eltrombopag is also one of the reasons for its higher price. Eltrombopag can stimulate the bone marrow to produce platelets, thereby effectively correcting thrombocytopenia caused by various diseases. Eltrombopag has an irreplaceable role in the treatment of certain diseases, which makes its market demand continue to be strong. The price of drugs is often affected by market supply and demand. When demand exceeds supply, prices will naturally rise.
In addition, there are differences in the prices of eltrombopag’s original drug and generic drugs. Original drugs refer to innovative drugs with intellectual property rights. The price of original drugs sold domestically and abroad is betweenmore than RMB 1,000-4,000. Generic drugs are drugs that are copied and produced by other pharmaceutical companies after the patent of the original drug expires. The current price of generic drugs sold overseas is about a few hundred yuan (the price may fluctuate due to the exchange rate).
For patients, facing high drug prices can indeed feel financial pressure. However, when choosing drugs, patients should not only consider price factors, but also pay attention to the efficacy and safety of the drugs. Although Eltrombopag is more expensive, its unique efficacy and safety in the treatment of thrombocytopenia have been widely recognized. Therefore, reasonable selection and use under the guidance of a doctor is crucial.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)